Pontifax
Finance · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
12 Hay Hl, London, Greater London, W1J 8...Phone Number
(407) 599-2200Website
www.pontifax.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
2
1
1
1
About Pontifax
Pontifax Venture Capital specializes in groundbreaking innovations in life sciences, focusing on transformative healthcare technologies across all development stages. The company actively scouts disruptive ideas in research centers and builds exceptional companies, providing hands-on guidance and networking to maximize success. They invest in clinical-stage companies, offering strategic direction and expertise in capital markets and mergers & acquisitions. With $1.2 billion managed, Pontifax has established 75 startups and continues to support early-stage and growth-stage ventures.Explore more
Pontifax Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pontifax your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Pontifax had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Pontifax has new funding data
Check if Pontifax has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Pontifax recently announced quarterly report
Check out if Pontifax is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Pontifax
Product Launch: Get notified when Pontifax launches new products
Pontifax, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Pontifax
Compare insights from companies similar to Pontifax, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pontifax is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Pontifax is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Pontifax.
Pontifax Tech Stack
A closer look at the technologies used by Pontifax
See more technologies
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Pontifax News & Media
Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline
Series A Financing extension led by Pontifax Venture Capital and existing investors Novo Holdings and Ysios Capital, raising an additional 31M EUR Funds will be used to ensure broad pan-sarcoma development of lead ADC asset uPARAP and to further advance second ADC pipeline asset Ohad...ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax ...
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) (“ProQR”), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, today announced that it has amended its convertible debt financing agreement entered into in 2020 with Kreos Capital (“Kreos”) and Pontifax Medison Debt Financing (“Pontifax”). The amended agreement provides ProQR with access to up to an additional $90 million89Bio Completes $60M Series A
SAN FRANCISCO, CA, 89Bio today announced it has closed a $60 million Series A financing.89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
SAN FRANCISCO and HERZLIYA, Israel, Oct. 25, 2018 /PRNewswire/ -- 89Bio, a clinical-stage biopharmaceutical company focused on nonalcoholic steatohepatitis (NASH) and other liver and metabolic disorders, today announced it has closed a $60 million Series A financing. The funding will be...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pontifax
Sign Up For FreeTo access detailed company insights
Pontifax Venture Capital specializes in groundbreaking innovations in life sciences, focusing on transformative healthcare technologies across all development stages. The company actively scouts disruptive ideas in research centers and builds exceptional companies, providing hands-on guidance and networking to maximize success. They invest in clini... Read More
